Requiring the Maryland Department of Health and the Prescription Drug Affordability Board jointly to study certain information regarding the payment of prescription drug claims under the Maryland Medical Assistance Program during calendar years 2021 and 2022 and how to address certain inconsistencies; and requiring the Department and the Board to report the findings of the study to the Maryland Medicaid Administration and certain committees of the General Assembly by October 31, 2023.